69287-13-4

Basic information

• Product Name: HEXYL P-METHOXYPHENYL KETONE
• Synonyms: TIMTEC-BB SBB008394;P-METHOXYHEPTANOPHENONE;P-ANISYL HEXYL KETONE;1-(4-METHOXY-PHENYL)-HEPTAN-1-ONE;HEXYL P-METHOXYPHENYL KETONE;1-(4-Methoxyphenyl)-1-heptanone;NISTC69287134
• CAS NO: 69287-13-4
• Molecular Formula: C₁₄H₂₀O₂
• Molecular Weight: 220.31
• Mol File: 69287-13-4.mol
• Article Data: 28

Chemical Properties

• Boiling Point: 335.3 °C at 760 mmHg
• Flash Point: 139 °C
• Appearance: /
• Density: 0.968 g/cm³
• Vapor Pressure: 0.000121mmHg at 25°C
• Refractive Index: 1.493
• CAS DataBase Reference: HEXYL P-METHOXYPHENYL KETONE(CAS DataBase Reference)
• NIST Chemistry Reference: HEXYL P-METHOXYPHENYL KETONE(69287-13-4)
• EPA Substance Registry System: HEXYL P-METHOXYPHENYL KETONE(69287-13-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 69287-13-4(Hazardous Substances Data)

Usage

General Description

Hexyl p-methoxyphenyl ketone, also known as IFF's trademarked trademarked "Isobutyl p-methoxycinnamate," is a clear, colorless to pale-yellow liquid with a sweet, floral, and honey-like odor. This chemical is commonly used as a fragrance ingredient in various cosmetic and personal care products, including perfumes, lotions, and soaps. It provides a sweet, floral scent with a hint of honey, making it a popular choice for adding a touch of warmth and sophistication to fragrances. In addition to its use in the cosmetic industry, hexyl p-methoxyphenyl ketone is also used in the manufacture of flavorings and food additives. It is considered safe for use in these applications and is regulated by various global regulatory bodies to ensure its safety for consumer use.

InChI:InChI=1/C14H20O2/c1-3-4-5-6-7-14(15)12-8-10-13(16-2)11-9-12/h8-11H,3-7H2,1-2H3

Upstream product

• 67132-63-2 Se-methyl heptaneselenoate 
• 100-66-3 methoxybenzene 
• 343922-50-9 C₂₁H₂₆OS 
• 111-14-8 oenanthic acid 
• 592-41-6 1-hexene 
• 105-13-5 4-Methoxybenzyl alcohol 
• 3761-92-0 n-hexylmagnesium bromide 
• 100-07-2 4-methoxy-benzoyl chloride 
• 4762-26-9 hexyltriphenylphosphonium bromide 
• 874-90-8 4-methoxybenzonitrile 
• 52898-49-4 4,N-dimethoxy-N-methylbenzamide 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 111-71-7 heptanal 
• 2528-61-2 Heptanoic acid chloride 

Downstream Products

• 17403-97-3 4-(1-Hexylpent-1-enyl)-anisol 
• 129182-23-6 1-methoxy-4-(oct-1-en-2-yl)benzene 
• 17404-41-0 1-hexyl-1-(4-methoxyphenyl)heptane 
• 17508-71-3 4-(1-Hexylheptyl)-phenol 
• 17404-35-2 4-(1-Butylheptyl)-anisol 
• 17508-62-2 4-(1-Butylheptyl)-phenol 
• 17572-30-4 2,6-Dinitro-4-(1-hexylheptyl)-phenol 
• 17726-35-1 2,6-Dinitro-4-(1-butylheptyl)-phenol 
• 120554-83-8 (E,E)-5-(4-methoxyphenyl)-2,4-undecadienoic acid 4-nitrophenyl ester 
• 120554-50-9 (E,E)-5-(4-methoxyphenyl)-2,4-undecadienoic acid 
• 17404-03-4 4-<1-Hexyll-hepten-(1)-yl>-anisol 

Relevant articles and documents

Development of Trifluoromethanesulfonic Acid-Immobilized Nitrogen-Doped Carbon-Incarcerated Niobia Nanoparticle Catalysts for Friedel-Crafts Acylation

Heterogeneous trifluoromethanesulfonic acid-immobilized nitrogen-doped carbon-incarcerated niobia nanoparticle catalysts (NCI-Nb-TfOH) that show excellent catalytic performance with low niobium loading (1 mol %) in Friedel-Crafts acylation have been developed. These catalysts exhibit higher activity and higher tolerance to catalytic poisons compared with the previously reported TfOH-treated NCI-Ti catalysts, leading to a broader substrate scope. The catalysts were characterized via spectroscopic and microscopic studies.

Ketide compounds, method for manufacturing, and use for treating diabetes thereof

The present invention relates to ketide compounds, as well as ketide compounds. The present invention relates to a method for preparing a ketide compound, and a use thereof, in which various anti-diabetic TMPA derivative designs can be induced, and is effective in comparison with existing multi-stage synthesis. In addition, the ketide compounds according to the present invention have strong AMPMPK activity and are expected to be useful as a therapeutic agent for diabetes. (by machine translation)

Pd-catalyzed Oxidative Cross-coupling of Alkyl Chromium(0) Fischer Carbene Complexes with Organoboronic Acids

Alkyl chromium(0) carbene complexes have been explored as the cross-coupling partners in the palladium-catalyzed reaction with aryl or alkenyl boronic acids. This coupling reaction displays the versatile reactivities of alkyl chromium(0) carbenes under palladium catalysis. Mechanistically, this transformation is proposed to involve deprotonation of the alkyl chromium carbene substrate to generate a vinyl chromium anion intermediate that undergoes transmetalation to organopalladium species and reductive elimination.